Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation
出版年份 2021 全文链接
标题
Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation
作者
关键词
-
出版物
BMC Medical Genomics
Volume 14, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-02-27
DOI
10.1186/s12920-021-00909-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
- (2020) Alexander Drilon et al. NATURE MEDICINE
- Diagnosis of fusion genes using targeted RNA sequencing
- (2019) Erin E. Heyer et al. Nature Communications
- High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no driver alteration detected by DNA sequencing and low tumor mutation burden
- (2019) Ryma Benayed et al. CLINICAL CANCER RESEARCH
- An Integrated Next-Generation Sequencing System for Analyzing DNA Mutations, Gene Fusions, and RNA Expression in Lung Cancer
- (2019) Brian C. Haynes et al. Translational Oncology
- Comparison of in Situ and Extraction-Based Methods for the Detection of ROS1 Rearrangements in Solid Tumors
- (2019) Carina Heydt et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Testing NTRK testing: Wet‐lab and in silico comparison of RNA‐based targeted sequencing assays
- (2019) Nicole Pfarr et al. GENES CHROMOSOMES & CANCER
- Targeted RNA‐sequencing assays: a step forward compared to FISH and IHC techniques?
- (2019) Gaëlle Tachon et al. Cancer Medicine
- EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer
- (2018) Petros Christopoulos et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer
- (2018) Jessica J. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of Crizotinib among Different Types of ROS1 Fusion Partners in Patients with ROS1 -Rearranged Non–Small Cell Lung Cancer
- (2018) Ziming Li et al. Journal of Thoracic Oncology
- Comparison of molecular testing modalities for detection of ROS1 rearrangements in a cohort of positive patient samples
- (2018) Kurtis D. Davies et al. Journal of Thoracic Oncology
- EGFR-RAD51 fusion variant in lung adenocarcinoma and response to erlotinib: A case report
- (2018) You-cai Zhu et al. LUNG CANCER
- Evaluation of commercial DNA and RNA extraction methods for high-throughput sequencing of FFPE samples
- (2018) Stine H. Kresse et al. PLoS One
- ALK- rearrangement in non-small-cell lung cancer (NSCLC)
- (2018) Xue Du et al. Thoracic Cancer
- Cabozantinib in patients with advanced RET -rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
- (2016) Alexander Drilon et al. LANCET ONCOLOGY
- Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
- (2016) Joshua D Campbell et al. NATURE GENETICS
- EGFR Fusions as Novel Therapeutic Targets in Lung Cancer
- (2016) K. Konduri et al. Cancer Discovery
- High-throughput diagnostic profiling of clinically actionable gene fusions in lung cancer
- (2015) Nicole Pfarr et al. GENES CHROMOSOMES & CANCER
- The distribution ofBRAFgene fusions in solid tumors and response to targeted therapy
- (2015) Jeffrey S. Ross et al. INTERNATIONAL JOURNAL OF CANCER
- Genomic alterations in lung adenocarcinoma
- (2015) Siddhartha Devarakonda et al. LANCET ONCOLOGY
- FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non-Small Cell Lung Cancer
- (2014) R. Wang et al. CLINICAL CANCER RESEARCH
- The landscape of kinase fusions in cancer
- (2014) Nicolas Stransky et al. Nature Communications
- ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non-Small Cell Lung Cancer
- (2013) J. F. Gainor et al. CLINICAL CANCER RESEARCH
- New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials
- (2013) William D. Travis et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
- (2013) Aria Vaishnavi et al. NATURE MEDICINE
- Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007
- (2013) Sarah Walters et al. THORAX
- Identification of Targetable FGFR Gene Fusions in Diverse Cancers
- (2013) Yi-Mi Wu et al. Cancer Discovery
- Identifying and Targeting ROS1 Gene Fusions in Non-Small Cell Lung Cancer
- (2012) K. D. Davies et al. CLINICAL CANCER RESEARCH
- Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
- (2012) D Ross Camidge et al. LANCET ONCOLOGY
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice
- (2011) L. V. Sequist et al. ANNALS OF ONCOLOGY
- A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing
- (2011) Y. S. Ju et al. GENOME RESEARCH
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
- (2011) Alice T Shaw et al. LANCET ONCOLOGY
- Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
- (2011) Caicun Zhou et al. LANCET ONCOLOGY
- Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers
- (2011) Chenguang Li et al. PLoS One
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- TheEML4-ALKfusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-typeEGFRandKRAS
- (2009) Daisy Wing-Sze Wong et al. CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started